M. Colleen Hastings
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
M. Colleen Hastings has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Robert J. Wyatt
Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN, USA
2 shared publications A. Osama Gaber
University of Tennessee Health Science Center (UTHSC)
1 shared publicationBettina H. Ault
University of Tennessee Health Science Center (UTHSC)
1 shared publicationDeborah P. Jones
University of Tennessee Health Science Center (UTHSC)
1 shared publicationKeith K. Lau
University of Tennessee Health Science Center (UTHSC)
1 shared publicationLillian W. Gaber
University of Tennessee Health Science Center (UTHSC)
1 shared publication
Latest Publications
- 1 May 2007
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (5) , 742-746
Diagnosis of de novo localized thrombotic microangiopathy by surveillance biopsy
Thrombotic microangiopathy has been reported in association with calcineurin inhibitors and less frequently with sirolimus in renal transplant patients. The diagnosis of thrombotic microangiopathy is typically made by diagnostic biopsy in the setting of allograft dysfunction. The finding of thrombotic microangiopathy on surveillance biopsy without a significant elevation of baseline serum creatinine is unusual. The optimal treatment of this disorder remains controversial. Treatment strategies have included dose adjustment, drug substitution, plasmapheresis, and intravenous immunoglobulin G. We report a case of de novo thrombotic microangiopathy diagnosed by surveillance biopsy in a patient without hematologic abnormalities or elevated serum creatinine. This patient had resolution of the renal lesion following conversion from tacrolimus to sirolimus-based immunosuppression.
- 1 May 2007
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (5) , 742-746
Diagnosis of de novo localized thrombotic microangiopathy by surveillance biopsy
Thrombotic microangiopathy has been reported in association with calcineurin inhibitors and less frequently with sirolimus in renal transplant patients. The diagnosis of thrombotic microangiopathy is typically made by diagnostic biopsy in the setting of allograft dysfunction. The finding of thrombotic microangiopathy on surveillance biopsy without a significant elevation of baseline serum creatinine is unusual. The optimal treatment of this disorder remains controversial. Treatment strategies have included dose adjustment, drug substitution, plasmapheresis, and intravenous immunoglobulin G. We report a case of de novo thrombotic microangiopathy diagnosed by surveillance biopsy in a patient without hematologic abnormalities or elevated serum creatinine. This patient had resolution of the renal lesion following conversion from tacrolimus to sirolimus-based immunosuppression.
- 1 February 2007
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (2) , 317-318
Renal survival in pediatric patients with IgA nephropathy
- 1 February 2007
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (2) , 317-318
Renal survival in pediatric patients with IgA nephropathy